Can a simple blood test make albumin therapy smarter for liver patients?
Disease control
Recruiting now
This study tests whether a biomarker can predict which people with advanced liver cirrhosis and fluid buildup (ascites) will benefit from regular albumin infusions. About 240 adults will receive either albumin or a placebo every 10 days for 6 months. The goal is to see if the bio…
Phase: PHASE3 • Sponsor: Aleksander Krag • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC